Chest
Clinical InvestigationsPULMONARY VASCULATUREDiffuse Pulmonary Arteriovenous Malformations: Characteristics and Prognosis
Section snippets
Materials and Methods
All patients with pulmonary AVMs (n = 351) who were seen in three hospitals (Saint Michael's Hospital, Yale New Haven Hospital, and Johns Hopkins Hospital) between 1980 and 1998 were screened for this study. The patients who were selected included only those with diffuse pulmonary AVMs, defined as AVMs involving every subsegmental artery of at least one lobe (Fig 1). This is contrasted with the more frequent presentation of multiple discrete pulmonary AVMs (Fig 2). Five of the patients
Results
Of the 351 pulmonary AVM patients who were identified during the 18-year interval, 16 patients (5%; 10 female and 6 male) had diffuse pulmonary AVMs (Table 1). Of these, HHT was definitively diagnosed in 12 patients (75%) and was suspected in 2 patients (13%). Although many had epistaxis in this group, only one had GI bleeding. Cerebral AVMs were not diagnosed in any of the patients. Interestingly, some had a family history of discrete pulmonary AVMs but none had a family history of diffuse
Discussion
Pulmonary AVMs are known to cause serious complications. These complications can be prevented if AVMs are managed appropriately with TCE. Little is known about the subgroup of patients with diffuse pulmonary AVMs. Many of the reported patients had a poor prognosis, although few of them had undergone any specific therapy. Their severe hypoxia and our inability to improve it with TCE has led some researchers to suggest that these patients undergo lung transplantation. We have demonstrated that
Conclusion
Patients with diffuse pulmonary AVMs have a fairly good prognosis and can lead productive lives. In a select group of these patients, small improvements in oxygenation can be obtained with PFR. However, patients with diffuse pulmonary AVMs are at increased risk for neurologic complications; therefore, antibiotic prophylaxis and TCE of the larger AVMs is of utmost importance.
References (40)
- et al.
Pulmonary telangiectasia: report of case proved by pulmonary biopsy
J Thorac Surg
(1954) - et al.
Pulmonary telangiectasia
Br J Dis Chest
(1979) - et al.
Multiple arteriovenous fistulas
Int J Cardiol
(1989) - et al.
Pulmonary arteriovenous fistulas
Am J Med
(1962) - et al.
Pulmonary arteriovenous malformations: diagnosis and transcatheter embolotherapy
J Vasc Interv Radiol
(1996) - et al.
Pregnancy and its outcomes in women with and without surgical treatment of congenital heart disease
Am J Cardiol
(1982) - et al.
Pulmonary arteriovenous malformations: techniques and long-term outcome of embolotherapy
Radiology
(1988) - et al.
Embolotherapy of large pulmonary arteriovenous malformations: long-term results
Ann Thorac Surg
(1997) - et al.
Pulmonary arteriovenous malformations: results of treatment with coil embolization in 53 patients
AJR Am J Roentgenol
(1995) - et al.
Pulmonary arteriovenous malformations: a state of the art review
Am J Respir Crit Care Med
(1998)
Telangiectasias of the lung
Q J Med
Pulmonary telangiectasia
AJR Am J Roentgenol
Clinical and angiographic features of pulmonary arteriovenous fistulas in children
Radiology
Widespread pulmonary lesions in a cyanotic woman
JAMA
Pulmonary arteriovenous fistulas
Herz
Progressive cyanosis in a child with hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease)
Pediatr Pulmonol
Diffuse pulmonary arteriovenous malformations (angiodysplasia with unusual histologic features): case report and review of the literature
Pediatr Pulmonol
Diffuse pulmonary arteriovenous malformation in a child with polysplenia syndrome
Pediatr Pathol Lab Med
The spectrum of pulmonary arteriovenous fistulae: clinico-pathological correlations
Thorac Cardiovasc Surg
Cyanosis due to pulmonary arteriovenous malformation
Am Fam Physician
Cited by (0)
This work was supported by a fellowship (for Dr. Faughnan) from the Canadian Lung Association/Glaxo/Medical Research Council of Canada, aswell as funding from the Nelson Arthur Hyland Foundation. Dr. Robert I.White, Jr. is supported in part by a grant from the Josephine Laurence Hopkins Foundation.